Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), developed by ...
Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical ...
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), ...
A class of antivirals called Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1 (HSV-1), the common ...
The press release below was prepared by University of Utah Health. View the original. In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing ...
Kyoto, Japan -- Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever ...
Explore how Pin1 inhibitors function as antivirals for herpes simplex virus, presenting a new avenue for HSV-1 therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback